Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention

References

• Crocker MK, Yanovski JA. Pediatric obesity: etiology and treatment. Endocrinol. Metab. Clin. North Am.38, 525–548 (2009).
   PubMed Web of Science ®Google Scholar
• Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA282, 1523–1529 (1999).
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Coxson P, Pletcher MJ et al. Adolescent overweight and future adult coronary heart disease. N. Engl. J. Med.357, 2371–2379 (2007).
   PubMed Web of Science ®Google Scholar
• Narayan KM, Boyle JP, Thompson TJ et al. Lifetime risk for diabetes mellitus in the United States. JAMA290, 1884–1890 (2003).
   PubMed Web of Science ®Google Scholar
• Olshansky SJ, Passaro DJ, Hershow RC et al. A potential decline in life expectancy in the United States in the 21st Century. N. Engl. J. Med.352, 1138–1145 (2005).
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Machann J et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med.168, 1609–1616 (2008).
   PubMed Web of Science ®Google Scholar
• Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med.168, 1617–1624 (2008).
   PubMed Web of Science ®Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care33, 562–568 (2010).
   PubMed Web of Science ®Google Scholar
• Dabelea D, Bell RA, D’Agostino RB Jr et al. Incidence of diabetes in youth in the United States. JAMA297, 2716–2724 (2007).
   PubMed Web of Science ®Google Scholar
• Mensah GA, Mokdad AH, Ford ES et al. State of disparities in cardiovascular health in the United States. Circulation111, 1233–1241 (2005).
   PubMed Web of Science ®Google Scholar
• Commonwealth Scientific Industrial Research Organisation. Australian National Children’s Nutrition and Physical Activity Survey – Main Findings. Department of Health and Ageing, Canberra, Australia (2008).
   Google Scholar
• Ogden CL, Carroll MD, Curtin LR et al. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA303, 242–249 (2010).
   PubMed Web of Science ®Google Scholar
• Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int. J. Pediatr. Obes.1, 11–25 (2006).
   PubMed Web of Science ®Google Scholar
• Lieb DC, Snow RE, DeBoer MD. Socioeconomic factors in the development of childhood obesity and diabetes. Clin. Sports Med.28, 349–378 (2009).
   PubMed Web of Science ®Google Scholar
• Freedman DS, Sherry B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics124(Suppl. 1), S23–S34 (2009).
   Web of Science ®Google Scholar
• de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem.54, 945–955 (2008).
   PubMed Web of Science ®Google Scholar
• Kimm SY, Barton BA, Obarzanek E et al. Racial divergence in adiposity during adolescence: The NHLBI Growth and Health Study. Pediatrics107, E34 (2001).
   PubMed Web of Science ®Google Scholar
• Gillum RF. Distribution of waist-to-hip ratio, other indices of body fat distribution and obesity and associations with HDL cholesterol in children and young adults aged 4–19 years: The Third National Health and Nutrition Examination Survey. Int. J. Obes. Relat. Metab. Disord.23, 556–563 (1999).
   PubMed Web of Science ®Google Scholar
• Reis JP, Araneta MR, Wingard DL et al. Overall obesity and abdominal adiposity as predictors of mortality in U.S. White and black adults. Ann. Epidemiol.19, 134–142 (2009).
   PubMedGoogle Scholar
• Herrera VM, Casas JP, Miranda JJ et al. Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int. J. Obes. (Lond.)33, 568–576 (2009).
   PubMedGoogle Scholar
• Park YW, Zhu S, Palaniappan L et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med.163, 427–436 (2003).
   PubMed Web of Science ®Google Scholar
• Walker SE, Gurka MJ, Oliver MN et al. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr. Metab. Cardiovasc. Dis. DOI: 10.1016/j.numecd.2010.05.006 (2010) (Epub ahead of print).
   Google Scholar
• Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of Type 2 diabetes mellitus. Diabetes58, 773–795 (2009).
   PubMed Web of Science ®Google Scholar
• Heron M. National Vital Statistics Reports. 58(14). National Center for Health Statistics, MD, USA (2010).
   Google Scholar
• Hinderliter AL, Blumenthal JA, Waugh R et al. Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. Am. J. Hypertens.17, 43–49 (2004).
   PubMed Web of Science ®Google Scholar
• Perregaux D, Chaudhuri A, Rao S et al. Brachial vascular reactivity in blacks. Hypertension36, 866–871 (2000).
   PubMed Web of Science ®Google Scholar
• Hinderliter AL, Sager AR, Sherwood A et al. Ethnic differences in forearm vasodilator capacity. Am. J. Cardiol.78, 208–211 (1996).
   PubMedGoogle Scholar
• Duck MM, Hoffman RP. Impaired endothelial function in healthy African–American adolescents compared with Caucasians. J. Pediatr.150, 400–406 (2007).
   Google Scholar
• Howard G, O’Leary DH, Zaccaro D et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation93, 1809–1817 (1996).
   PubMed Web of Science ®Google Scholar
• Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation112, 32–38 (2005).
   PubMed Web of Science ®Google Scholar
• DeBoer MD. Underdiagnosis of the metabolic syndrome in non-Hispanic black adolescents: a call for ethnic-specific criteria. Curr. Cardiovasc. Risk Rep.4, 302–310 (2010).
   Google Scholar
• Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol.25, 4–7 (2004).
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med.14, 222–231 (2008).
   PubMed Web of Science ®Google Scholar
• Martin LJ, Woo JG, Daniels SR et al. The relationships of adiponectin with insulin and lipids are strengthened with increasing adiposity. J. Clin. Endocrinol. Metab.90, 4255–4259 (2005).
   Google Scholar
• Stefan N, Bunt JC, Salbe AD et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J. Clin. Endocrinol. Metab.87, 4652–4656 (2002).
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and Type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab.86, 1930–1935 (2001).
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab.13, 84–89 (2002).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med.7, 941–946 (2001).
   PubMed Web of Science ®Google Scholar
• Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J. Pediatr.129, 440–443 (1996).
   PubMed Web of Science ®Google Scholar
• Lee S, Bacha F, Gungor N, Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care29, 51–56 (2006).
   Google Scholar
• Ferrannini E, Gastaldelli A, Matsuda M et al. Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. J. Clin. Endocrinol. Metab.88, 3251–3257 (2003).
   PubMed Web of Science ®Google Scholar
• Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in African–American and Hispanic children. Diabetes Care25, 2184–2190 (2002).
   PubMed Web of Science ®Google Scholar
• Preeyasombat C, Bacchetti P, Lazar AA et al. Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children. J. Pediatr.146, 474–481 (2005).
   Google Scholar
• Nguyen TT, Keil MF, Russell DL et al. Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J. Pediatr.138, 474–480 (2001).
   Google Scholar
• Meng YX, Ford ES, Li C et al. Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999–2002. Clin. Chem.53, 2152–2159 (2007).
   Google Scholar
• Rodden AM, Diaz VA, Mainous AG et al. Insulin resistance in adolescents. J. Pediatr.151, 275–279 (2007).
   Google Scholar
• Stefan N, Stumvoll M, Weyer C et al. Exaggerated insulin secretion in Pima Indians and African–Americans but higher insulin resistance in Pima Indians compared to African–Americans and Caucasians. Diabet. Med.21, 1090–1095 (2004).
   Google Scholar
• Pradhan AD, Manson JE, Rifai N et al. C-reactive protein, interleukin 6, and risk of developing Type 2 diabetes mellitus. JAMA286, 327–334 (2001).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med.347, 1557–1565 (2002).
   PubMed Web of Science ®Google Scholar
• DeBoer MD, Gurka MJ, Sumner AE. Diagnosis of the metabolic syndrome is associated with disproportionately high levels of high-sensitivity C-reactive protein in non-Hispanic black adolescents: an analysis of NHANES 1999–2006. Diabetes Care34, DOI: 10.2337/dc2310–1877 (2011) (Epub ahead of print).
   Google Scholar
• Wee CC, Mukamal KJ, Huang A et al. Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring)16, 875–880 (2008).
   PubMed Web of Science ®Google Scholar
• Lazzer S, Vermorel M, Montaurier C et al. Changes in adipocyte hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents. Int. J. Obes. (Lond.)29, 1184–1191 (2005).
   Google Scholar
• Kynde I, Heitmann BL, Bygbjerg IC et al. Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later. Metabolism58, 1817–1824 (2009).
   PubMed Web of Science ®Google Scholar
• Winer JC, Zern TL, Taksali SE et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J. Clin. Endocrinol. Metab.91, 4415–4423 (2006).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation109, 433–438 (2004).
   PubMed Web of Science ®Google Scholar
• DeBoer MD, Gurka MJ. Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with Type 2 diabetes and cardiovascular disease: data from the National Health and Nutrition Examination Survey 1999–2006. Metab. Syndr. Relat. Disord.8, 343–353 (2010).
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Cook S et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation115, 2526–2532 (2007).
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti G, Kaufman F et al. The metabolic syndrome in children and adolescents. Lancet369, 2059–2061 (2007).
   PubMed Web of Science ®Google Scholar
• Morrison JA, Friedman LA, Wang P et al. Metabolic syndrome in childhood predicts adult metabolic syndrome and Type 2 diabetes mellitus 25 to 30 years later. J. Pediatr.152, 201–206 (2008).
   PubMed Web of Science ®Google Scholar
• Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J. Pediatr155, e7–e11 (2009).
   Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med.23, 469–480 (2006).
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Zhao G et al. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care31, 587–589 (2008).
   Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Kaufman F et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr. Diabetes8, 299–306 (2007).
   PubMed Web of Science ®Google Scholar
• Nathan DM, Davidson MB, DeFronzo RA et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care30, 753–759 (2007).
   PubMed Web of Science ®Google Scholar
• Gaillard T. Insulin resistance and cardiovascular disease risk in black people of the African diaspora. Curr. Cardio. Risk Rep.4, 186–194 (2010).
   Google Scholar
• Martinez-Vizcaino V, Martinez MS, Aguilar FS et al. Validity of a single-factor model underlying the metabolic syndrome in children: a confirmatory factor analysis. Diabetes Care33, 1370–1372 (2010).
   Google Scholar
• Blades B, Vega GL, Grundy SM. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb.13, 1227–1235 (1993).
   Google Scholar
• Clarenbach JJ, Vega GL, Adams-Huet B et al. Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans. J. Investig. Med.55, 187–194 (2007).
   Google Scholar
• Vega GL, Clark LT, Tang A et al. Hepatic lipase activity is lower in African American men than in white American men: effects of 5´ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res.39, 228–232 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents, National Health and Nutrition Examination Survey (NHANES), 2001–2006. Arch. Pediatr. Adolesc. Med.163, 371–377 (2009).
   PubMed Web of Science ®Google Scholar
• Bower JF, Deshaies Y, Pfeifer M et al. Ethnic differences in postprandial triglyceride response to a fatty meal and lipoprotein lipase in lean and obese African American and Caucasian women. Metabolism51, 211–217 (2002).
   Google Scholar
• Despres JP, Couillard C, Gagnon J et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol.20, 1932–1938 (2000).
   PubMed Web of Science ®Google Scholar
• Friday KE, Srinivasan SR, Elkasabany A et al. Black–white differences in postprandial triglyceride response and postheparin lipoprotein lipase and hepatic triglyceride lipase among young men. Metabolism48, 749–754 (1999).
   Google Scholar
• Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis196, 696–703 (2008).
   PubMed Web of Science ®Google Scholar
• Savoye M, Shaw M, Dziura J et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA297, 2697–2704 (2007).
   PubMed Web of Science ®Google Scholar
• Wickham EP, Stern M, Evans RK et al. Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment. Metab. Syndr. Relat. Disord.7, 179–186 (2009).
   Google Scholar
• Johnston CA, Tyler C, McFarlin BK et al. Weight loss in overweight Mexican American children: a randomized, controlled trial. Pediatrics120, e1450–e1457 (2007).
   Google Scholar
• Naar-King S, Ellis D, Kolmodin K et al. A randomized pilot study of multisystemic therapy targeting obesity in African–American adolescents. J. Adolesc. Health45, 417–419 (2009).
   PubMed Web of Science ®Google Scholar
• Jelalian E, Hart CN, Mehlenbeck RS et al. Predictors of attrition and weight loss in an adolescent weight control program. Obesity (Silver Spring)16, 1318–1323 (2008).
   PubMed Web of Science ®Google Scholar
• Tershakovec AM, Kuppler K. Ethnicity, insurance type, and follow-up in a pediatric weight management program. Obes. Res.11, 17–20 (2003).
   Google Scholar
• Wing RR, Anglin K. Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care19, 409–413 (1996).
   PubMed Web of Science ®Google Scholar
• Zeller M, Kirk S, Claytor R et al. Predictors of attrition from a pediatric weight management program. J. Pediatr.144, 466–470 (2004).
   PubMed Web of Science ®Google Scholar
• Kumanyika SK, Obarzanek E, Stevens VJ et al. Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am. J. Clin. Nutr.53, 1631S–1638S (1991).
   PubMed Web of Science ®Google Scholar
• West DS, Elaine Prewitt T, Bursac Z et al. Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program. Obesity (Silver Spring)16, 1413–1420 (2008).
   PubMed Web of Science ®Google Scholar
• Marshall SJ, Jones DA, Ainsworth BE et al. Race/ethnicity, social class, and leisure-time physical inactivity. Med. Sci. Sports Exerc.39, 44–51 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson-Taylor WL, Fisher RA, Hubbard VS et al. The change in weight perception of weight status among the overweight: comparison of NHANES III (1988–1994) and 1999–2004 NHANES. Int. J. Behav. Nutr. Phys. Act.5, 9 (2008).
   PubMed Web of Science ®Google Scholar
• Yancey AK, Simon PA, McCarthy WJ et al. Ethnic and sex variations in overweight self-perception: relationship to sedentariness. Obesity (Silver Spring)14, 980–988 (2006).
   PubMed Web of Science ®Google Scholar
• Foti K, Lowry R. Trends in perceived overweight status among overweight and nonoverweight adolescents. Arch. Pediatr. Adolesc. Med.164, 636–642 (2010).
   PubMedGoogle Scholar
• Huang JS, Becerra K, Oda T et al. Parental ability to discriminate the weight status of children: results of a survey. Pediatrics120, e112–e119 (2007).
   Web of Science ®Google Scholar
• Maynard LM, Galuska DA, Blanck HM et al. Maternal perceptions of weight status of children. Pediatrics111, 1226–1231 (2003).
   PubMed Web of Science ®Google Scholar
• McCabe MP, Ricciardelli LA. Sociocultural influences on body image and body changes among adolescent boys and girls. J. Soc. Psychol.143, 5–26 (2003).
   PubMed Web of Science ®Google Scholar
• Rhee KE, De Lago CW, Arscott-Mills T et al. Factors associated with parental readiness to make changes for overweight children. Pediatrics116, e94–e101 (2005).
   PubMed Web of Science ®Google Scholar
• Butterworth SW. Influencing patient adherence to treatment guidelines. J. Manag. Care Pharm.14, 21–24 (2008).
   PubMed Web of Science ®Google Scholar
• Suarez M, Mullins S. Motivational interviewing and pediatric health behavior interventions. J. Dev. Behav. Pediatr.29, 417–428 (2008).
   Google Scholar
• Goetz T. 75 million Americans may have something called metabolic syndrome. How Big Pharma turned obesity into a disease – then invented the drugs to cure it. Wired10, 152–157 (2006).
   Google Scholar
• Eisenmann JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc. Diabetol.7, 17 (2008).
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care28, 2289–2304 (2005).
   PubMed Web of Science ®Google Scholar
• Morrison JA, Glueck CJ, Horn PS et al. Childhood predictors of adult Type 2 diabetes at 9- and 26-year follow-ups. Arch. Pediatr. Adolesc. Med.164, 53–60 (2010).
   PubMed Web of Science ®Google Scholar
• Weiss R, Taksali SE, Tamborlane WV et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care28, 902–909 (2005).
   PubMed Web of Science ®Google Scholar
• Executive summary: standards of medical care in diabetes – 2009. Diabetes Care32(Suppl. 1), S6–S12 (2009).
   PubMed Web of Science ®Google Scholar
• International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care32, 1327–1334 (2009).
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Rifai N, Buring JE et al. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am. J. Med.120, 720–727 (2007).
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med.350, 1387–1397 (2004).
   PubMed Web of Science ®Google Scholar
• Melbye H, Hvidsten D, Holm A et al. The course of C-reactive protein response in untreated upper respiratory tract infection. Br. J. Gen. Pract.54, 653–658 (2004).
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med.346, 393–403 (2002).
   PubMed Web of Science ®Google Scholar